Featured

FDA Renews Medical Imaging Drugs Advisory Committee
7/7/2017
On July 3, the FDA announced that it is renewing the Charter for the Medical Imaging Drugs Advisory Committee for an additional two years. According to the announcement, the Commissioner has determined that it is in the public interest to renew the Advisory Committee, which reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in diagnostic and therapeutic procedures using radioactive pharmaceuticals and contrast media used in diagnostic radiology. The new charter will be in effect until May 18, 2019. 
Read the full notice on the Federal Register.

Latest

PA Introduces Licensure Bill
7/31/2017
Rep. Bryan Cutler, a former medical imaging professional, has introduced a patient safety measure in the Pennsylvania House of Representatives that establishes licensure standards for nonphysician personnel who perform medical imaging examinations and radiation therapy treatments and creates the Pennsylvania Medical Imaging and Radiation Therapy Board of Examiners.
Read more at ASRT.

IA Proposed Rule on Mammography Reports and Radiation
7/31/2017
Proposed rule of the Department of Public Health amends regulations under 641 IAC 41.6 concerning safety requirements for the use of radiation machines. The rule requires physician mammography reports and patient lay letters to include language and educational references regarding the patient's breast density and resulting risk of cancer incidence and impacts on mammography interpretation related to increased tissue density. Comments are due Aug. 8, 2017. Contact: Angela Leek; DPH, Bureau of Radiological Health; 515-281-3478; angela.leek@idph.iowa.gov.

ACR Offers Summary of Radiology Provisions in 2018 HOPPS Proposed Rule
7/28/2017
In this rule, CMS proposes changes that affect radiology including the addition of one level to the imaging APC families, the delayed elimination of the CT and MR cost centers and the implementation of two modifiers for use on claims for plain film and computed radiography X-ray services. These changes, if finalized would be effective January, 1, 2018. 
Read more at ACR.


 
2018 MPFS Proposed Rule Summary—IDTFs Face Cuts
7/28/2017
The ACR detailed analysis of the Calendar Year 2018 Medicare Physician Fee Schedule Proposed Rule has found that independent diagnostic testing facilities (IDTFs) face an aggregate 6 percent cut in their fee schedule payment rates, while most medical imaging practitioners will probably see few changes in their rates if the rule is implemented as proposed.
Read more at ACR.

CA Enacts Balance Billing Restrictions
7/21/2017
The California Radiological Society (CRS) is working with state regulators to implement a new law that bans balance billing while assuring fair compensation to radiologists and other physicians who provide noncontracted services to patients covered by narrow-network managed care. 
Proposed 2018 OPPS offers some positives for radiology
7/21/2017
On July 13, CMS released a proposed rule for the 2018 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System that includes some positive changes for radiology -- the most important being a delay in changing how CT and MRI costs are calculated.
Read more at AuntMinnie.com.

CMS releases 2018 MPFS with 1% radiology pay cut
7/21/2017
CMS on July 13 released a proposed rule for the Medicare Physician Fee Schedule (MPFS) for 2018 that includes a 1% cut in payments for radiology services.
Read more at AuntMinnie.com.

FDA Renews Medical Imaging Drugs Advisory Committee
7/7/2017
On July 3, the FDA announced that it is renewing the Charter for the Medical Imaging Drugs Advisory Committee for an additional two years. According to the announcement, the Commissioner has determined that it is in the public interest to renew the Advisory Committee, which reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in diagnostic and therapeutic procedures using radioactive pharmaceuticals and contrast media used in diagnostic radiology. The new charter will be in effect until May 18, 2019. 
Read the full notice on the Federal Register.